Grace Lim, MD, MS

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Grace Lim, MD, MS sits in the top decile of US sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count).

10 total trials 1 currently recruiting 9 completed early-phase tilt top decile by trial count

Grace Lim, MD, MS: 10 sponsored US clinical trials, 1 recruiting.

Grace Lim, MD, MS sponsors 10 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 9 completed. 0 of these trials are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Labor Pain, with 1 trials.

Top-decile sponsor footprint

Grace Lim, MD, MS ranks in the top decile of sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

10 total, page 1 of 1

RECRUITING Phase 1

Ketamine Pharmacokinetics and Pharmacodynamics for Postpartum Depression and Pain After Cesarean Delivery

NCT06767566
COMPLETED NA

Hypotension Prediction Index to Predict Epidural-labor Analgesia Induced Hypotension

NCT05906368
COMPLETED Phase 1

Ketamine Tolerated Dose for Postpartum Depression and Pain After Cesarean Delivery (PREPARE 1)

NCT05907213
COMPLETED Phase 2

Effectiveness of Clonidine, Dexmedetomidine, and Fentanyl Adjuncts for Labor Epidural Analgesia

NCT05487196
COMPLETED

Precision Opioid Care After Cesarean Delivery (PRECISE-CD)

NCT05280743
COMPLETED NA

Virtual Reality Biofeedback for Postpartum Anxiety and Depression

NCT04925765
COMPLETED NA

BRIDGE Percutaneous Nerve Stimulation for Cesarean Delivery Pain Control

NCT04365465
COMPLETED Phase 2

Ketamine to Improve Recovery After Cesarean Delivery - Part 1

NCT04037085
COMPLETED NA

NSS-Bridge Device for Post-Cesarean Delivery Pain

NCT03830307
COMPLETED NA

CSE v. Epidural for Postpartum Depression

NCT03022526

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 2 2

Therapeutic Areas

Labor Pain 1
Depression, Postpartum 1
Postpartum Depression 1
Pain 1
Pain, Postoperative 1
Opioid Use Disorder 1

What is open in the Grace Lim, MD, MS pipeline

1 recruiting of 10 indexed (10% open); 9 completed (90%).

Phase mix: 0 late (III/IV) vs 4 early (I/II) (early-phase heavy).

Top condition: Labor Pain (1 trial), 5 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Grace Lim, MD, MS: open-pipeline peers nationwide

Peers matched on 10 registered trials and 10% open enrollment, not the therapeutic-area sidebar.

Grace Lim, MD, MS sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 510152025 0%10%20%30%40% Total trials Recruiting share Grace Lim, MD, MSAdamas PharmaceuticalsAdverum BiotechnologiesAevi Genomic Medicine, LLC, a Cerecor companyAgouron PharmaceuticalsAbiomedAimmune TherapeuticsAltria Client ServicesAlzheimer's Disease Cooperative Study (ADCS)
Grace Lim, MD, MS sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Grace Lim, MD, MS sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 10 trials (± recruiting share)

Sponsors near 10% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Grace Lim, MD, MS page

10 registered trials is a research-attention snapshot, not an endorsement of Grace Lim, MD, MS or any single study.

  • 1 of Grace Lim, MD, MS's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Labor Pain is the condition Grace Lim, MD, MS studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Labor Pain trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Grace Lim, MD, MS pipeline card: 10 registered trials from official public datasets.Report a data error.